Asahi Life Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.19M | Sell |
990
-371
| -27% | -$379K | 0.67% | 33 |
|
|
2026
Q1 | $1.25M | Sell |
1,361
-432
| -24% | -$438K | 0.81% | 29 |
|
|
2025
Q4 | $1.93M | Sell |
1,793
-159
| -8% | -$152K | 1.07% | 25 |
|
|
2025
Q3 | $1.49M | Sell |
1,952
-67
| -3% | -$49.9K | 0.83% | 28 |
|
|
2025
Q2 | $1.57M | Buy |
2,019
+153
| +8% | +$119K | 0.92% | 26 |
|
|
2025
Q1 | $1.54M | Buy |
1,866
+680
| +57% | +$566K | 1% | 24 |
|
|
2024
Q4 | $916K | Sell |
1,186
-870
| -42% | -$720K | 0.56% | 37 |
|
|
2024
Q3 | $1.82M | Buy |
2,056
+108
| +6% | +$97.1K | 1.1% | 24 |
|
|
2024
Q2 | $1.76M | Buy |
1,948
+440
| +29% | +$352K | 1.21% | 22 |
|
|
2024
Q1 | $1.17M | Sell |
1,508
-825
| -35% | -$587K | 0.7% | 30 |
|
|
2023
Q4 | $1.36M | Buy |
2,333
+600
| +35% | +$350K | 0.73% | 32 |
|
|
2023
Q3 | $931K | Sell |
1,733
-12
| -0.7% | -$6.18K | 0.32% | 48 |
|
|
2023
Q2 | $818K | Buy |
1,745
+690
| +65% | +$289K | 0.27% | 48 |
|
|
2023
Q1 | $362K | Sell |
1,055
-185
| -15% | -$62.4K | 0.12% | 107 |
|
|
2022
Q4 | $454K | Sell |
1,240
-620
| -33% | -$220K | 0.15% | 80 |
|
|
2022
Q3 | $601K | Buy |
1,860
+735
| +65% | +$233K | 0.19% | 52 |
|
|
2022
Q2 | $365K | Sell |
1,125
-2,380
| -68% | -$714K | 0.1% | 84 |
|
|
2022
Q1 | $1M | Buy |
3,505
+60
| +2% | +$15.4K | 0.14% | 49 |
|
|
2021
Q4 | $952K | Sell |
3,445
-240
| -7% | -$60.8K | 0.12% | 50 |
|
|
2021
Q3 | $851K | Buy |
3,685
+2,020
| +121% | +$499K | 0.12% | 52 |
|
|
2021
Q2 | $382K | Sell |
1,665
-970
| -37% | -$195K | 0.05% | 121 |
|
|
2021
Q1 | $492K | Sell |
2,635
-2,830
| -52% | -$554K | 0.07% | 94 |
|
|
2020
Q4 | $923K | Buy |
5,465
+200
| +4% | +$29.9K | 0.12% | 60 |
|
|
2020
Q3 | $779K | Buy |
5,265
+2,820
| +115% | +$436K | 0.12% | 54 |
|
|
2020
Q2 | $401K | Sell |
2,445
-3,745
| -61% | -$575K | 0.07% | 86 |
|
|
2020
Q1 | $859K | Buy |
+6,190
| New | +$851K | 0.15% | 48 |
|
|
2019
Q4 | – | Sell |
-2,700
| Closed | -$302K | – | 231 |
|
|
2019
Q3 | $302K | Buy |
2,700
+910
| +51% | +$101K | 0.05% | 134 |
|
|
2019
Q2 | $198K | Buy |
1,790
+70
| +4% | +$8.24K | 0.04% | 185 |
|
|
2019
Q1 | $223K | Sell |
1,720
-180
| -9% | -$21.9K | 0.04% | 160 |
|
|
2018
Q4 | $220K | Buy |
+1,900
| New | +$212K | 0.03% | 158 |
|
Other funds holding LLY
Asahi Life Asset Management's LLY Position: Q2 2026 in Review
Asahi Life Asset Management reduced its Eli Lilly (LLY) stake by 27% in Q2 2026, selling an estimated $379K and leaving 990 shares worth $1.19M. The position accounts for 0.67% of the portfolio, ranked #33.
Asahi Life Asset Management first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $1.93M in Q4 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Asahi Life Asset Management held 990 shares of Eli Lilly worth $1.19M as of Q2 2026.
- Asahi Life Asset Management sold 371 Eli Lilly shares in Q2 2026, an estimated $379K.
- Eli Lilly made up 0.67% of Asahi Life Asset Management's portfolio in Q2 2026, its #33 holding.
- Asahi Life Asset Management first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
- Asahi Life Asset Management's Eli Lilly position peaked at $1.93M in Q4 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Asahi Life Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.